School of Medicine
Showing 1-14 of 14 Results
-
Jen Haensel
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.
I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots. -
Md Enamul Haque
Biostatistician 3, Ophthalmology Research/Clinical Trials
Current Role at StanfordSr. Research Data Scientist
-
Mary Elizabeth Hartnett, MD
Michael F. Marmor, M.D. Professor of Retinal Science and Disease and Professor of Ophthalmology
BioMary Elizabeth Hartnett, MD, is the Michael F. Marmor, M.D. Professor in Retinal Science and Diseases and is a Professor of Ophthalmology at Stanford University. Dr. Hartnett is the director of Pediatric Retina at Stanford University and principal investigator of a retinal angiogenesis laboratory, in which she studies causes and treatments for diseases including retinopathy of prematurity and age-related macular degeneration. She created the first-ever academic textbook on the subject, Pediatric Retina, in its third edition, which has proven to be an invaluable resource for residents and ophthalmologists internationally.
Dr. Hartnett’s NIH-funded laboratory of vascular biology and angiogenesis has studied mechanisms causing pathology in age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). Her work in AMD has been to understand the mechanisms involved in activation and invasion of choroidal endothelial cells anterior to the RPE in order to maintain vasculature that is physiologic and not damaging beneath the RPE. Her lab has elucidated environmental stressors that lead to scarring in the macula for which no vision improvement is currently possible. The goal is to find methods to prevent the scarring.
Her lab’s work in ROP provided the proof of concept to regulate an angiogenic signaling pathway by inhibiting VEGF to facilitate intraretinal neovascularization as well as to inhibit abnormal extraretinal neovascularization and reduce retinal destruction used in previous treatments. Her work has been translated through clinical trials to lead to new treatments for severe ROP and has represented a paradigm shift in the understanding and treatment of severe ROP.
Dr. Hartnett has received numerous awards, including the Weisenfeld Award, the highest award for clinician-scientists given by the Association for Research in Vision and Ophthalmology (ARVO), in 2018, and is an ARVO Gold Fellow. She received the 2019 Paul Kayser/Retina Research Foundation Global Award, the Macula Society’s 2016 Paul Henkind Award and its 2019 Arnall Patz Medal, the Paul Kayser/RRF Global Award from the PanAmerica Society, and the 2021 Suzanne Veronneau-Troutman Award, the most prestigious award from Women in Ophthalmology. In 2022, she was one of six at the University of Utah to receive a distinguished research award, for Pediatrics and Ophthalmology.
Dr. Hartnett's prolific publication record includes 227 articles in peer-reviewed journals and over 40 book chapters. She has delivered numerous national and international invited lectures. Her long list of professional committee work includes serving as chair of the Publications Committee of ARVO, as a mentor for the ARVO Leadership Development Program, and in leadership positions internationally as chair of the research advisory committees for The Macula Society and the Jack McGovern Coats Disease Foundation as well as Chair of the Credentialing Committee for The Retina Society. She reviews manuscripts for more than 20 eye and science journals and serves on the editorial boards of PlosOne, Molecular Vision, and the American Journal of Ophthalmology. Dr. Hartnett is a Fellow of the American College of Surgeons (FACS) and a Silver and Gold Fellow of the Association for Research in Vision and Ophthalmology (FARVO). -
Yang Hu, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsThe ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.
More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure. -
Xiaojing Huang
Postdoctoral Scholar, Ophthalmology
BioXiaojing earned her Bachelor of Science in Optical Engineering, graduating cum laude, from the University of Rochester in 2018. Continuing her academic journey at the same institution, she began her graduate studies in optics in the spring of 2019. Under the supervision of Professors Julie Bentley and Alfredo Dubra, she completed her PhD in 2024. The same year, Xiaojing joined Stanford University as a postdoctoral researcher, furthering her exploration and contributions to the field of adaptive optics retinal imaging.
-
Jia-Horung Hung
Affiliate, Ophthalmology Research/Clinical Trials
Visiting Scholar, Ophthalmology Research/Clinical TrialsBioDr. Jia-Horung Hung is an ophthalmologist with specialties in uveitis and retina. He is a member of several professional societies, including The Ophthalmological Society of Taiwan, the American Academy of Ophthalmology, the Taiwan Retinal Society, and the Taiwan Ocular Inflammation Society (TOIS), where he served as Secretary General from 2020 to 2023.
Dr. Hung’s research interests include ocular inflammation, infections, surgical techniques, hereditary ocular diseases, and ophthalmic big-data analysis. He has received recognition for his work, including the Young Investigator Research Award in Clinical Medicine from the School of Medicine, National Cheng Kung University, as well as Best Presentation awards at academic meetings. He has also been acknowledged for his teaching contributions and was part of the team awarded a Gold Medal and Best Hardware at the 2020 International Genetically Engineered Machine (iGEM) competition.
His laboratory research focuses on age-related macular degeneration, hereditary ocular diseases, and antimicrobial photodynamic therapy for eye infections. Since November 2023, Dr. Hung has been a visiting scholar at Professor Quan Dong Nguyen’s lab at Stanford University, gaining further experience in the diagnosis and treatment of ocular inflammatory diseases, as well as in ophthalmology research and clinical trials.
